Gérald Voss
Impact in
- Virology top 0.2%
- HIV Research and Treatment
-
- Malaria Research and Control
- Mosquito-borne diseases and control
Papers in
- Virology 56
- HIV Research and Treatment 55
- Poxvirus research and outbreaks 1
-
- Malaria Research and Control 14
- Mosquito-borne diseases and control 1
- Co-authors
- Joe Cohen (13 shared papers)Kent E. Kester (11 shared papers)John R. Mascola (5 shared papers)Marguerite Koutsoukos (12 shared papers)David C. Montefiori (5 shared papers)Norman L. Letvin (9 shared papers)Nadia Tornieporth (7 shared papers)Paul Goepfert (2 shared papers)
- Journals
- Vaccine (18 papers)Journal of Virology (10 papers)Virology (5 papers)PLoS ONE (5 papers)Journal of General Virology (5 papers)
- Partner nations
- United StatesBelgiumGermany
In The Last Decade
Gérald Voss
84 papers receiving 5.6k citations
Gérald Voss's Hit Papers
Peers
Comparison fields: 5 of 57
- Virology 2.8k
- Public Health, Environmental and Occupational Health 1.5k
- Immunology 271
- Infectious Diseases 243
- Biotechnology 24
Countries citing papers authored by Gérald Voss
This map shows the geographic impact of Gérald Voss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérald Voss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérald Voss more than expected).
Fields of papers citing papers by Gérald Voss
This network shows the impact of papers produced by Gérald Voss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérald Voss. The network helps show where Gérald Voss may publish in the future.
Co-authors
The 25 scholars most cited alongside Gérald Voss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 86 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies Hit paper breakdown → | 2005 | 993 |
| 2 | 2001 | 449 | |
| 3 | 2015 | 264 | |
| 4 | 2001 | 231 | |
| 5 | 2004 | 229 | |
| 6 | 1996 | 217 | |
| 7 | 2003 | 212 | |
| 8 | 2011 | 180 | |
| 9 | 2005 | 147 | |
| 10 | 2006 | 145 | |
| 11 | 1999 | 144 | |
| 12 | 1996 | 127 | |
| 13 | 1996 | 121 | |
| 14 | 2009 | 108 | |
| 15 | 2007 | 93 | |
| 16 | 2004 | 90 | |
| 17 | 2006 | 88 | |
| 18 | 2006 | 88 | |
| 19 | 2018 | 88 | |
| 20 | 2015 | 80 |
About Gérald Voss
Gérald Voss is a scholar working on Virology, Public Health, Environmental and Occupational Health, Infectious Diseases, Obstetrics and Gynecology and Immunology, having authored 86 papers that have together received 5.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (55 papers), Malaria Research and Control (14 papers), Tuberculosis Research and Epidemiology (5 papers), Immunotherapy and Immune Responses (1 paper), Viral-associated cancers and disorders (1 paper), Mosquito-borne diseases and control (1 paper), COVID-19 Impact on Reproduction (1 paper) and Poxvirus research and outbreaks (1 paper). The work is most often cited by research in Virology (2.8k citations), Public Health, Environmental and Occupational Health (1.5k citations), Immunology (271 citations), Infectious Diseases (243 citations) and Biotechnology (24 citations). Gérald Voss has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Joe Cohen, Kent E. Kester, John R. Mascola, Marguerite Koutsoukos, David C. Montefiori, Norman L. Letvin, Nadia Tornieporth, Paul Goepfert, Martine Delchambre and Feng Gao. Their work appears in journals such as Vaccine, Journal of Virology, Virology, PLoS ONE and Journal of General Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.